Cargando…

Recomendaciones sobre el manejo de pacientes adultos con enfermedades reumáticas en el contexto de la infección por SARS-CoV-2/COVID-19. Asociación Colombiana de Reumatología

OBJECTIVE: To produce recommendations for patients with rheumatological diseases receiving immunomodulatory and immunosuppressive therapies (conventional drugs, biologicals, and small molecules) during the COVID-19 pandemic. MATERIALS AND METHODS: The recommendations were determined using the Delphi...

Descripción completa

Detalles Bibliográficos
Autores principales: Saldarriaga Rivera, Lina María, Fernández Ávila, Daniel, Bautista Molano, Wilson, Jaramillo Arroyave, Daniel, Bautista Ramírez, Alain Jasaf, Díaz Maldonado, Adriana, Hernán Izquierdo, Jorge, Jáuregui, Edwin, Latorre Muñoz, María Constanza, Restrepo, Juan Pablo, Segura Charry, Juan Sebastián
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290203/
http://dx.doi.org/10.1016/j.rcreu.2020.05.007
_version_ 1783545621645361152
author Saldarriaga Rivera, Lina María
Fernández Ávila, Daniel
Bautista Molano, Wilson
Jaramillo Arroyave, Daniel
Bautista Ramírez, Alain Jasaf
Díaz Maldonado, Adriana
Hernán Izquierdo, Jorge
Jáuregui, Edwin
Latorre Muñoz, María Constanza
Restrepo, Juan Pablo
Segura Charry, Juan Sebastián
author_facet Saldarriaga Rivera, Lina María
Fernández Ávila, Daniel
Bautista Molano, Wilson
Jaramillo Arroyave, Daniel
Bautista Ramírez, Alain Jasaf
Díaz Maldonado, Adriana
Hernán Izquierdo, Jorge
Jáuregui, Edwin
Latorre Muñoz, María Constanza
Restrepo, Juan Pablo
Segura Charry, Juan Sebastián
author_sort Saldarriaga Rivera, Lina María
collection PubMed
description OBJECTIVE: To produce recommendations for patients with rheumatological diseases receiving immunomodulatory and immunosuppressive therapies (conventional drugs, biologicals, and small molecules) during the COVID-19 pandemic. MATERIALS AND METHODS: The recommendations were determined using the Delphi method as an agreement tool. A panel of experts was formed, with academic backgrounds and research experience in rheumatology. A literature search was conducted and 42 questions were generated. The level of agreement was made with 80% of approval by the participants. RESULTS: A group of eleven rheumatologists from 7 cities in the country participated. The response rate was 100% for the three consultation rounds. In the first round, agreement was reached on 35 questions, on 37 in the second round, and on 42 questions in the third round. CONCLUSION: The recommendation for the majority of the pharmacological treatments used in rheumatology is to continue with immunomodulatory or immunosuppressive therapies in patients who do not have the infection, and to suspend it in patients with a diagnosis of SARS-CoV-2/COVID-19.
format Online
Article
Text
id pubmed-7290203
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-72902032020-06-12 Recomendaciones sobre el manejo de pacientes adultos con enfermedades reumáticas en el contexto de la infección por SARS-CoV-2/COVID-19. Asociación Colombiana de Reumatología Saldarriaga Rivera, Lina María Fernández Ávila, Daniel Bautista Molano, Wilson Jaramillo Arroyave, Daniel Bautista Ramírez, Alain Jasaf Díaz Maldonado, Adriana Hernán Izquierdo, Jorge Jáuregui, Edwin Latorre Muñoz, María Constanza Restrepo, Juan Pablo Segura Charry, Juan Sebastián Revista Colombiana de Reumatología Article OBJECTIVE: To produce recommendations for patients with rheumatological diseases receiving immunomodulatory and immunosuppressive therapies (conventional drugs, biologicals, and small molecules) during the COVID-19 pandemic. MATERIALS AND METHODS: The recommendations were determined using the Delphi method as an agreement tool. A panel of experts was formed, with academic backgrounds and research experience in rheumatology. A literature search was conducted and 42 questions were generated. The level of agreement was made with 80% of approval by the participants. RESULTS: A group of eleven rheumatologists from 7 cities in the country participated. The response rate was 100% for the three consultation rounds. In the first round, agreement was reached on 35 questions, on 37 in the second round, and on 42 questions in the third round. CONCLUSION: The recommendation for the majority of the pharmacological treatments used in rheumatology is to continue with immunomodulatory or immunosuppressive therapies in patients who do not have the infection, and to suspend it in patients with a diagnosis of SARS-CoV-2/COVID-19. Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. 2020 2020-06-12 /pmc/articles/PMC7290203/ http://dx.doi.org/10.1016/j.rcreu.2020.05.007 Text en © 2020 Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Saldarriaga Rivera, Lina María
Fernández Ávila, Daniel
Bautista Molano, Wilson
Jaramillo Arroyave, Daniel
Bautista Ramírez, Alain Jasaf
Díaz Maldonado, Adriana
Hernán Izquierdo, Jorge
Jáuregui, Edwin
Latorre Muñoz, María Constanza
Restrepo, Juan Pablo
Segura Charry, Juan Sebastián
Recomendaciones sobre el manejo de pacientes adultos con enfermedades reumáticas en el contexto de la infección por SARS-CoV-2/COVID-19. Asociación Colombiana de Reumatología
title Recomendaciones sobre el manejo de pacientes adultos con enfermedades reumáticas en el contexto de la infección por SARS-CoV-2/COVID-19. Asociación Colombiana de Reumatología
title_full Recomendaciones sobre el manejo de pacientes adultos con enfermedades reumáticas en el contexto de la infección por SARS-CoV-2/COVID-19. Asociación Colombiana de Reumatología
title_fullStr Recomendaciones sobre el manejo de pacientes adultos con enfermedades reumáticas en el contexto de la infección por SARS-CoV-2/COVID-19. Asociación Colombiana de Reumatología
title_full_unstemmed Recomendaciones sobre el manejo de pacientes adultos con enfermedades reumáticas en el contexto de la infección por SARS-CoV-2/COVID-19. Asociación Colombiana de Reumatología
title_short Recomendaciones sobre el manejo de pacientes adultos con enfermedades reumáticas en el contexto de la infección por SARS-CoV-2/COVID-19. Asociación Colombiana de Reumatología
title_sort recomendaciones sobre el manejo de pacientes adultos con enfermedades reumáticas en el contexto de la infección por sars-cov-2/covid-19. asociación colombiana de reumatología
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290203/
http://dx.doi.org/10.1016/j.rcreu.2020.05.007
work_keys_str_mv AT saldarriagariveralinamaria recomendacionessobreelmanejodepacientesadultosconenfermedadesreumaticasenelcontextodelainfeccionporsarscov2covid19asociacioncolombianadereumatologia
AT fernandezaviladaniel recomendacionessobreelmanejodepacientesadultosconenfermedadesreumaticasenelcontextodelainfeccionporsarscov2covid19asociacioncolombianadereumatologia
AT bautistamolanowilson recomendacionessobreelmanejodepacientesadultosconenfermedadesreumaticasenelcontextodelainfeccionporsarscov2covid19asociacioncolombianadereumatologia
AT jaramilloarroyavedaniel recomendacionessobreelmanejodepacientesadultosconenfermedadesreumaticasenelcontextodelainfeccionporsarscov2covid19asociacioncolombianadereumatologia
AT bautistaramirezalainjasaf recomendacionessobreelmanejodepacientesadultosconenfermedadesreumaticasenelcontextodelainfeccionporsarscov2covid19asociacioncolombianadereumatologia
AT diazmaldonadoadriana recomendacionessobreelmanejodepacientesadultosconenfermedadesreumaticasenelcontextodelainfeccionporsarscov2covid19asociacioncolombianadereumatologia
AT hernanizquierdojorge recomendacionessobreelmanejodepacientesadultosconenfermedadesreumaticasenelcontextodelainfeccionporsarscov2covid19asociacioncolombianadereumatologia
AT jaureguiedwin recomendacionessobreelmanejodepacientesadultosconenfermedadesreumaticasenelcontextodelainfeccionporsarscov2covid19asociacioncolombianadereumatologia
AT latorremunozmariaconstanza recomendacionessobreelmanejodepacientesadultosconenfermedadesreumaticasenelcontextodelainfeccionporsarscov2covid19asociacioncolombianadereumatologia
AT restrepojuanpablo recomendacionessobreelmanejodepacientesadultosconenfermedadesreumaticasenelcontextodelainfeccionporsarscov2covid19asociacioncolombianadereumatologia
AT seguracharryjuansebastian recomendacionessobreelmanejodepacientesadultosconenfermedadesreumaticasenelcontextodelainfeccionporsarscov2covid19asociacioncolombianadereumatologia